当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析 - 现金流量表

智飞生物

(300122)

  

流通市值:294.03亿  总市值:497.67亿
流通股本:14.14亿   总股本:23.94亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金7,507,829,380.153,823,275,963.5936,933,180,960.4128,433,944,110.9
  收到其他与经营活动有关的现金40,814,335.2723,179,926.73139,707,254.0481,168,614.2
  经营活动现金流入小计7,548,643,715.423,846,455,890.3237,072,888,214.4528,515,112,725.1
  购买商品、接受劳务支付的现金3,866,010,465.32,439,691,420.1935,476,050,758.7726,712,896,152.95
  支付给职工以及为职工支付的现金913,928,832.59513,121,152.571,809,219,214.871,352,024,739.43
  支付的各项税费249,300,999.73103,390,316.692,070,230,637.591,841,854,981.93
  支付其他与经营活动有关的现金955,028,729.31486,097,911.12,131,376,918.421,673,305,575.52
  经营活动现金流出小计5,984,269,026.933,542,300,800.5541,486,877,529.6531,580,081,449.83
  经营活动产生的现金流量净额1,564,374,688.49304,155,089.77-4,413,989,315.2-3,064,968,724.73
二、投资活动产生的现金流量:
  收回投资收到的现金4,000,0004,000,000--
  处置固定资产、无形资产和其他长期资产收回的现金净额6,817,645.66,364,945.64,759,655.974,655,142.17
  投资活动现金流入小计10,817,645.610,364,945.64,759,655.974,655,142.17
  购建固定资产、无形资产和其他长期资产支付的现金259,397,490.09149,039,120.66930,343,067.65700,478,076.61
  投资活动现金流出小计259,397,490.09149,039,120.66930,343,067.65700,478,076.61
  投资活动产生的现金流量净额-248,579,844.49-138,674,175.06-925,583,411.68-695,822,934.44
三、筹资活动产生的现金流量:
  取得借款收到的现金7,721,175,247.565,944,415,356.7214,738,177,057.9410,264,152,391.26
  收到其他与筹资活动有关的现金3,459,226.759,6001,162,393.71,159,935.2
  筹资活动现金流入小计7,724,634,474.265,944,474,956.7214,739,339,451.6410,265,312,326.46
  偿还债务支付的现金9,015,838,545.515,675,011,084.2610,198,541,3037,271,638,267
  分配股利、利润或偿付利息支付的现金146,234,36262,785,984.652,527,812,210.421,998,082,020.62
  支付其他与筹资活动有关的现金12,888,115.984,233,575.99315,099,068.05310,952,729.18
  筹资活动现金流出小计9,174,961,023.495,742,030,644.913,041,452,581.479,580,673,016.8
  筹资活动产生的现金流量净额-1,450,326,549.23202,444,311.821,697,886,870.17684,639,309.66
四、汇率变动对现金及现金等价物的影响-443,332.42-122,611.31,252,023.78-801,413.27
五、现金及现金等价物净增加额-134,975,037.65367,802,615.23-3,640,433,832.93-3,076,953,762.78
  加:期初现金及现金等价物余额2,698,856,401.982,698,856,401.986,339,290,234.916,339,290,234.91
  期末现金及现金等价物余额2,563,881,364.333,066,659,017.212,698,856,401.983,262,336,472.13
补充资料:
  净利润-597,095,590.86-2,018,478,513.91-
  资产减值准备386,776,453.58-655,340,773.1-
  固定资产和投资性房地产折旧221,754,519.31-348,442,188.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧221,754,519.31-348,442,188.25-
  无形资产摊销22,464,701.99-27,346,564.24-
  长期待摊费用摊销8,447,401.05-16,235,199.86-
  处置固定资产、无形资产和其他长期资产的损失-5,815,453.17--46,946.97-
  固定资产报废损失246,079.48-362,278.84-
  公允价值变动损失-2,355,610.36---
  财务费用156,744,146.88-141,498,348.61-
  递延所得税-178,451,500.89--372,957,916.55-
  其中:递延所得税资产减少-174,553,502.23--359,306,509.09-
    递延所得税负债增加-3,897,998.66--13,651,407.46-
  存货的减少1,136,682,711.41--13,253,831,856.99-
  经营性应收项目的减少2,422,358,062.14-10,172,547,509.29-
  经营性应付项目的增加-2,013,908,746.21--4,180,133,372.66-
  现金的期末余额2,563,881,364.33-2,698,856,401.98-
  减:现金的期初余额2,698,856,401.98-6,339,290,234.91-
  现金及现金等价物的净增加额-134,975,037.65--3,640,433,832.93-
公告日期2025-08-192025-04-222025-04-222024-10-26
审计意见(境内)标准无保留意见
TOP↑